Galapagos NV (GLPG) Financials
GLPG Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 4.7 billion | 1.9 billion |
2023-06-30 | 4.9 billion | 2.1 billion |
2023-03-31 | 5.0 billion | 2.3 billion |
2022-12-31 | 5.1 billion | 2.4 billion |
GLPG Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -129.2 million | -29.2 million |
2023-06-30 | -140.5 million | 30.0 million |
2023-03-31 | -108.1 million | ? |
2022-12-31 | -201.4 million | 40.2 million |
GLPG Net Income
No data available :(
GLPG Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 4.0 billion | - | 15.0 million |
2023-06-30 | 4.2 billion | - | 16.8 million |
2023-03-31 | 4.3 billion | - | 17.4 million |
2022-12-31 | 4.4 billion | - | 23.5 million |
GLPG Shares Outstanding
GLPG Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 3.4 million | 106.2 million | 17.5 million | 72.1 million |
2023-06-30 | 4.1 million | 117.8 million | 52.4 million | 9.6 million |
2023-03-31 | 4.7 million | 112.8 million | 31.9 million | 31.4 million |
2022-12-31 | 8.4 million | 162.1 million | 62.8 million | 17.3 million |
GLPG Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 127.1 million | 6.0 million |
2023-06-30 | 163.0 million | 4.6 million |
2023-03-31 | 195.0 million | 3.9 million |
2022-12-31 | 102.1 million | 4.4 million |
GLPG
Price: $29.09
52 week price:
Earnings Per Share: -2.54 USD
P/E Ratio: -15.32
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 69406
Ebitda: -23.5 millionMarket Capitalization: 2.1 billion